BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
See today's BioWorld Asia
Home
» Other news to note for March 30, 2021
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Other news to note for March 30, 2021
March 30, 2021
No Comments
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: Ajinomoto, Allianthera, Ascentage, Biontech, Bright Peak, CDC, Cerecor, Cipla, Clinuvel, Curevac, Evelo, Exagen, Fairjourney Biologics, Hoth, Hutchison China Meditech, Immunoprecise Antibodies, Insilico Medicine, Iontas, Johnson & Johnson, Kaleido, Kazia, Kyowa Kirin, Menarini, Mitsubishi Tanabe, Moderna, Neurobo, Nippon Shinyaku, Nobelpharma, Novadiscovery, Open Orphan, Pfizer, Pierre Fabre, Probiogen, RDIF, Sanofi, Siga Technologies, Simcere, Takeda, Twist, Y-Biologics, Zenas.
BioWorld Asia
Briefs
Other news to note